Stan Grossman

One physician discusses her experience with opting out of Medicare and offers advice to physicians considering doing the same.

Study had longest follow-up to date of a size cohort of clozapine users.

Clinicians should realize the potential harm ADHD medications may pose to maturing bones, and consider nutritional counseling.

A five question screening tool focusing on middle-age educational and occupational attainment helps predict dementia risk.

The sensors could potentially lead to new treatments as well as early disease detection.

Monoclonal antibodies targeting tau and amyloid beta in Alzheimer’s disease may benefit other neurodegenerative diseases.

Researchers identify significantly higher levels of neurogranin in patients with Alzheimer’s disease versus cognitively normal patients.

NPT088, from NeuroPhage Pharmaceuticals, targets proteins related to amyloid beta, tau.

TRV 101, from Treventis Corp., may prevent the formation of beta amyloid.

Metabolites detected in saliva test can be added to the diagnostic armamentarium in Alzheimer’s disease.

Researchers have identified biomarkers that have the potential to identify those at risk of developing Alzheimer’s disease.